AVR anteris technologies global corp.

Ann: Data Update on First-in-Human Study of DurAVR at NY Valves, page-44

  1. 558 Posts.
    lightbulb Created with Sketch. 349
    Very well said Suzuki....

    "The SP should be over $100 but we’re being played."

    I agree with you here, we should be WELL over $100 as my own valuation (based on IP + TAVR performance + estimated time to market) I have our valuation at US$3 Billion or in Aus$4.5 Billion..... we're currently at Aus$370 million.

    John Seaberg recently said at the AGM that in 45 years working in the cardiovascular space he had NEVR seen a device with the potential that the DurAVR has.

    John, I believe, will ultimately be proven correct.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$6.03
Change
0.010(0.17%)
Mkt cap ! $93.45M
Open High Low Value Volume
$6.00 $6.16 $5.80 $52.24K 8.792K

Buyers (Bids)

No. Vol. Price($)
1 857 $5.83
 

Sellers (Offers)

Price($) Vol. No.
$6.45 1000 1
View Market Depth
Last trade - 15.36pm 20/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.